deferoxamine and vlx600

deferoxamine has been researched along with vlx600 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brandt, P; Bremberg, U; D'Arcy, P; Fryknäs, M; Gullbo, J; Larsson, R; Linder, S; Nygren, P; Olofsson, MH; Persson, I; Schughart, LK; Senkowski, W; Zhang, X	1

Other Studies

1 other study(ies) available for deferoxamine and vlx600

Article	Year
Iron chelators target both proliferating and quiescent cancer cells. Scientific reports, 2016, 12-07, Volume: 6 Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Dose-Response Relationship, Drug; HCT116 Cells; HT29 Cells; Humans; Hydrazones; Inhibitory Concentration 50; Iron Chelating Agents; MCF-7 Cells; Mitochondria; Ribonucleotide Reductases; Structure-Activity Relationship; Triazoles	2016

Article

Year

Iron chelators target both proliferating and quiescent cancer cells.

Scientific reports, 2016, 12-07, Volume: 6

Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Dose-Response Relationship, Drug; HCT116 Cells; HT29 Cells; Humans; Hydrazones; Inhibitory Concentration 50; Iron Chelating Agents; MCF-7 Cells; Mitochondria; Ribonucleotide Reductases; Structure-Activity Relationship; Triazoles

2016